Edition:
United States

Profile: Cipla Ltd (CIPL.BO)

CIPL.BO on Bombay Stock Exchange

593.25INR
24 Mar 2017
Change (% chg)

Rs-3.30 (-0.55%)
Prev Close
Rs596.55
Open
Rs592.65
Day's High
Rs597.75
Day's Low
Rs591.50
Volume
212,311
Avg. Vol
103,186
52-wk High
Rs621.90
52-wk Low
Rs458.25

Cipla Limited is a holding company. The Company is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.

Company Address

Cipla Ltd

Mumbai Central
MUMBAI     400013
P: +9122.24826000
F: +9122.24826893

Company Web Links